R only
c. This quality control range applicable only to Haemophilus influenzae ATCC 49247 tested by broth microdilution
procedure using Haemophilus Test Medium (HTM)4
BACTRIMTM
d. This quality contro range applicable to tests performed by the broth microdilution method only using
brand of sulfamethoxazole and trimethoprim DS
cation. adjusted Mueller Hinton broth with 2% to 5% lysed horse blood4.
(double strength) TABLETS and TABLETS, USP
Diffusion Techniques:
Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the sus-
DESCRIPTION
ceptibility of bacteria to antimicrobial compounds One such standardized procedure5 requires the use of stan of
BACTRIM (sulfamethoxazole and trimethoprim) is a syn-
dardized inoculum concentrations. This procedure uses paper disks impregnated with .25/23. ug
thetic antibacterial combination product available DS
sulfamethoxazole/trimethoprim
test
the
susceptibility
of
microorganisms
sulfamethoxazole/trimethoprim.
(double strength) tablets, each containing 800 mg sul-
Reports from the laboratory providing results of the standard single-disk susceptibility test with 1.25/23.75
famethoxazole and 160 mg trimethoprim; tablets, each
ug of ulfamethoxazole/trimethoprim disk should be interpreted according the following criteria:
containing 400 mg sulfamethoxazole and 80 mg trimetho-
For testing either Enterobacteriaceae or Haemophilus influenzaee
prim for ora administration.
Sulfamethoxazole sulfanil-
Zone Diameter (mm)
Interpretation
amide; molecular formula almost
216
Susceptible (S)
white, odorless tasteless compound with molecular
11 - 15
weight of 253.28 and the following structural formula:
(I)
<10
Resistant (R)
These zone diameter standards are applicable only for disk diffusion testing with Haemophilus influenzae
and Haemophilus Test Medium (HTM)5
When testing Streptococcus pneumoniaef
Zone Diameter (mm)
Interpretation
219
(S)
Trimethoprim is diamino- trimethoxybenzyl)pyrimidine the molecular formula is 14H18N4O3 It
Intermediate (I)
a
white to light yellow, odorless, bitter compound with a molecular weight of 290.3. has the following struc
s15
Resistant (R)
tural formula:
f.
These zone diameter interpretative standards are applicable only to tests performed using Mueller-Hinton
agar
supplemented
with
5%
defibrinated
sheep
blood
when
incubated
in
5%
Interpretation should be as stated above for results using dilution techniques. Interpretation involves correlation
of the diameter obtained the disk test with the MIC for sulfamethoxazole/trimethoprim
Quality Control
with standardized dilution techniques, diffusion methods require the use laboratory control microorganisms
that
are
used
to
control
the
technical
aspects
of
the
laboratory
procedures
For
the
diffusion
technique,
the
1.25/23.75 ug sulfamethoxazole/trimethoprim disk* should provide the following zone diameters in these labora-
tory test quality control strains:
CH3C
Microorganism
Zone Diameter Ranges (mm)
OCH3
Escherichia
ATCC 25922
24-32
Inactive ingredients: Docusate sodium 85%, sodium benzoate 15%, sodium starch glycolate, magnesium
Haemophilus influenzaeg
ATCC 49247
24-32
stearate and pregelatinized starch.
Streptococcus pneumoniaeh
ATCC 49619
20-28
CLINICAL PHARMACOLOGY
*Mueller Hinton agar should be checked for excessive levels of thymidine or thymine. To determine whether
BACTRIM is rapidly absorbed following oral administration. Both sulfamethoxazole and trimethoprim exist the
medium has sufficiently low levels of thymidine and thymine, an faecalis (ATCC
blood unbound, protein-bound and metabolized forms; sulfamethoxazole also exists the conjugated form.
29212 or ATCC 33186) may be tested with sulfamethoxazole/trimethoprim disks zone inhibition 220 mm
The metabolism of sulfamethoxazole occurs predominately N4-acetylation, although the glucuronide conjugate
that
is
essentially
free
of
fine
colonies
indicates
sufficiently
low
level
of
thymidine
and
thymine.
has been identified. principal metabolites of trimethoprin are the 1- and 3-oxides and the 3' and '-hydroxy
g.
This quality control range applicable only to Haemophilus influenzae ATCC 49247 tested by a disk diffusion
derivatives. The free forms and are considered be the therapeutically active
procedure using Haemophilus Test Medium (HTM)5.
forms.
Approximately
70%
of
sulfamethoxazole
and
44%
of
trimethoprim
are
bound
to
plasma
proteins
The
h. This quality control range applicable only to tests performed by disk diffusion using Mueller-Hinton agar
presence of 10 mg percent sulfamethoxazole in plasma decreases the protein binding of trimethoprim by an
supplemented with 5% defibrinated sheep blood when incubated in 5% CO25
insignificant degree; trimethoprim does not influence the protein binding sulfamethoxazole
INDICATIONS AND USAGE
Peak
blood
levels
for
the
individual
components
occur
to
hours
after
oral
administration.
mean
serum
half-
lives
of
Urinary Tract Infections: For the treatment of urinary tract infections due to susceptible strains of the following
and trimethoprim are 10 and to 10 hours, respectively. However, patients with severely impaired
organisms Escherichia coli, Klebsiella species, Enterobacter species, Morganella morganii, Proteus mirabilis and
exhibit an increase in the of both components, requiring dosage regimen adjustment (see DOSAGE AND
Proteus vulgaris It is recommended that initial episodes uncomplicated urinary tract infections be treated with
ADMINISTRATION section) Detectable amounts of sulfamethoxazole and trimethoprim are present in the blood 24 hours
a single effective antibacterial agent rather than the combination.
after
drug
administration.
During
administration
800
sulfamethoxazole
and
160
mg
trimethoprim
b.i.d.
the
mean
steady-
state concentration of trimethoprim was 1.72 The steady-state mean levels of free and total
plasma ug/mL. plasma sul-
Acute Otitis Media: For the treatment of acute otitis media pediatric patients due susceptible strains
of
famethoxazole were ug/mt and 68.0 ug/mL, respectively. These levels were achieved after three days
Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician sulfamethoxa.
drug
Excretion
of
sulfamethoxazole
and
trimethoprim
primarily
by
the
kidneys
through
both
glomerula
zole and trimethoprim offers some advantage over the use of other antimicrobia agents. To date, there are
tration tubular secretion Urine both and trimethoprim considerably higher than
limited data the safety of repeated use of BACTRIM pediatric patients under two years of age. BACTRIM
are the concentrations in the blood average percentage of the dose recovered urine from O to 72 hours after single
is
not
indicated
for
prophylactic
or
prolonged
administratio
in
otitis
media
any
age
oral dose of sulfamethoxazole and trimethoprim is 84.5% for total sulfonamide and 66.8% for free trimethoprim. Thirty per-
Acute Exacerbations Chronic Bronchitis Adults: For treatment acute exacerbations chronic bronchitis due
cent of the tota sulfonamide excreted as free sulfamethoxazole, with the remaining as I4-acetylated metabolite.2 When
to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when in the judgment of the physician
administered together sulfamethoxazole and trimethoprim, neither sulfamethoxazole nor trimethoprim affects the urinary
BACTRIM offers some advantage over the use of single antimicrobial agent.
excretion pattern of the other.
Shigellosis: For the treatment of enteritis caused by susceptible strains of Shigella flexneri and Shigella sonnei
Both
sulfamethoxazole
and
trimethoprim
distribute
to
sputum
vaginal
fluid
and
middle
ear
fluid;
trimethoprim
when antibacterial therapy is indicated.
also distributes to bronchial secretion, and both pass the placental barrier and are excreted in human milk.
Pneumocystis Carinii Pneumonia: For the treatment of documented Pneumocystis carinii pneumonia and for
Geriatric Pharmacokinetics: The pharmacokinetics of sulfamethoxazole 800 mg and trimethoprim 160 mg were
prophylaxis against Pneumocystis carinii pneumonia individuals who are immunosuppressed and considered
studied
in
6
geriatric
subjects
(mean
age:
78.6
years)
and
6
young
healthy
subjects
(mean
age:
29.3
years)
to
be
at
an
increased
risk
of
developing
Pneumocystis
carinii
pneumonia.
using non-Us approved formulation. Pharmacokinetic values for sulfamethoxazole geriatric subjects were
Traveler's Diarrhea Adults: For the treatment of traveler's diarrhea due to susceptible strains of enterotoxi-
similar to those observed in young adult subjects. The mean renal clearance of trimethoprim was significantly
genic
coli
lower
in
geriatric
subjects
compared
with
young
adul
subjects
(19
mL/h/kg
vs
55
mL/h/kg).
However,
after
CONTRAINDICATIONS
normalizing by body weight the apparen total body clearance of trimethoprim was on average 19% lower
BACTRIM is contraindicated in patients with a known hypersensitivity trimethoprim or sulfonamides and in
geriatric subjects compared with young adult subjects.
patients with documented megaloblastic anemia due to folate deficiency BACTRIM is also contraindicated in preg:
Microbiology
nant patients and nursing mothers, because sulfonamides pass the placenta and are excreted in the milk and may
Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA)
cause kernicterus BACTRIM contraindicated pediatric patients less than months of age BACTRIM also
Trimethoprim blocks the production of tetrahydrofolic acid from dihydrofolic acid by binding to and reversibly inhibiting
contraindicated in patients with marked hepatic damage or with severe renal insufficiency when renal function
the required enzyme dihydrofolate reductase Thus, sulfamethoxazole and trimethoprim blocks two consecutive steps
status cannot be monitored.
the biosynthesis of nucleic acids and proteins essential to many bacteria.
WARNINGS
In vitro studies have shown that bacterial resistance develops more slowly with both sulfamethoxazole and
FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE HAVE
trimethoprim combination than with either sulfamethoxazole trimethoprim alone
OCCURRED DUE TO SEVERE REACTIONS. INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPI-
Sulfamethoxazole
and
trimethoprim
have
been
shown
to
be
active
against
most
strains
the
following
microor-
DERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA AND
ganisms, vitro and clinical infections as described in the INDICATIONS AND USAGE section.
OTHER BLOOD DYSCRASIAS.
Aerobic gram-positive microorganisms:
SULFONAMIDES, INCLUDING SULFONAMIDE- CONTAINING PRODUCTS SUCH AS SULFAMETHOXA-
ZOLE/TRIMETHOPRIM, SHOULD BE DISCONTINUED AT THE FIRST APPEARANCE OF SKIN RASH OR ANY
Streptococcus pneumoniae
SIGN OF ADVERSE REACTION. In rare instances, skin rash may be followed by more severe reaction, such
Aerobic gram-negative microorganisms:
-Johnsor syndrome, toxic epidermal necrolysis, hepatic necrosis, and serious blood disorders (see
Escherichia coli (including susceptible enterotoxigenic strains implicated in traveler's diarrhea)
PRECAUTIONS). Clinical signs, such rash, sore throat, fever, arthralgia, pallor, purpura jaundice may be
Klebsiella species
early
indications
of
serious
reactions.
Enterobacter species
Cough, shortness breath, and pulmonary infiltrates are hypersensitivity reactions of the respiratory tract
Haemophilus influenzae
that have been reported in association with sulfonamide treatment.
Morganella morganii
The
sulfonamides
should
not
be
used
for
treatment
of
group
A
B-hemolytic
streptococcal
infections.
In
an
Proteus
mirabilis
established infection, they wil not eradicate the streptococcus and, therefore, will not prevent sequelae such
Proteus vulgaris
as rheumatic fever.
Shigella flexneri
Shigella sonnei3
Pseudomembranous colitis has been reported with nearly all antibacterial agents, including sul-
famethoxazole/trimethoprim, and may range in severity from mild life-threatening. Therefore, it is
Other Organisms:
important to consider this diagnosis in patients who present with diarrhea subsequent to the adminis-
Pneumocystis carinii
tration of antibacterial agents.
Susceptibility Testing Methods:
Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia
Dilution Techniques:
Studies indicate that toxin produced by Clostridium difficile is one primary cause of "antibiotic-associated
Quantitative methods are used to determine antimicrobia minimum inhibitory concentrations (MICs). These
colitis.
MICs provide estimates of the susceptibility bacteria to antimicrobial compounds The MICs should be deter-
After the diagnosis of pseudomembranous colitis has been established therapeutic measures should be initiated
mined using standardized procedure. Standardized procedures are based on dilution method4 (broth or
Mild cases nembranous colitis usually respond drug discontinuation alone moderate to severe cases,
agar) with standardized inoculum and standardized concentrations of sul-
consideration should be given to management with fluids and electrolytes, protein supplementation, and treatment
famethoxazole/trimethoprim powder. The MIC values should be interpreted according to the following criteria:
with an ti-bacteria drug effective against difficile.
For testing Enterobacteriaceae:
PRECAUTIONS
MIC (ug/mL)
Interpretation
General: BACTRIM should be given with caution to patients with impaired rena or hepatic function, to those with
<2/38
Susceptible (S)
folate
deficiency
the
elderly,
chronic
alcoholics,
patients
receiving
anticonvulsant
therapy
patients
24/76
Resistant (R)
When testing either Haemophilus influenzaea Streptococcus pneumoniaeb:
asthma. with malabsorption In glucose- syndrome, -phosphate and patients deficient individuals, states) and hemolysis to those with severe occur. allergies This reaction or bronchial is fre-
MIC (ug/mL)
Interpretationb
quently dose -related. (see CLINICAL PHARMACOLOGY and DOSAGE AND ADMINISTRATION)
s0.5/9.5
Susceptible (S)
Cases of hypoglycemia non-diabetic patients treated with BACTRIM are seen rarely, usually occurring after
1/19-2/38
Intermediate (I)
a few days therapy. Patients with rena dysfunction, liver disease, malnutrition those receiving high doses
24/76
Resistant (R)
BACTRIM are particularly at risk.
These interpretative standards are applicable only to broth microdilution susceptibility tests with Haemophilus
Hematological changes indicative of folic acid deficiency may occur elderly patients patients with preexisting
influenzae
using
Haemophilus
Test
Medium
(HTM)4
folic acid deficiency or kidney failure. These effects are reversible by folinic acid therapy.
b These interpretative standards are applicable only to broth microdilution susceptibility tests using cation adjusted
Trimethoprim has been noted to impair phenylalanine metabolism but this significance phenyike-
Mueller Hinton broth with 2% to 5% lysed horse blood4
tonuric
patients
on
appropriate
dietary
restriction.
A report of "Susceptible" indicated that the pathogen is likely to be inhibited if the antimicrobial compound in
As with all drugs containing sulfonamides, caution advisable in patients with porphyria or thyroid dysfunction.
the blood reaches the concentrations usually achievable report of indicates that the result should
Use in the Treatment of and Prophylaxis for Pneumocystis Carinii Pneumonia in Patients with Acquired
be
considered
equivocal,
and
if
the
microorganism
is
not
frilly
susceptible
to
alternative,
clinically
feasible
drugs,
the vides physiologically test buffer should concentrated be repeated. which prevents This or in category situations small uncontrolled implies where possible high technical dosage clinical factors of applicability drug from can be in used. body major This sites discrepancies category where the also in drug inter. pro is
Immunodeficiency manner AIDS Syndrome patients. The (AIDS): incidence AIDS patients side effects may not particularly tolerate or rash respond fever to leukopenia BACTRIM and in the elevated same
aminotransferase (transaminase) values, with BACTRIM therapy AIDS patients who are being treated for
zone
causing
Pneumocystis
carinii
pneumonia
reported
to
be
greatly
increased
compared
with
the
incidence
nor-
pretation A report of "Resistant" indicates that the pathogen is not likely to be inhibited if the antimicrobial
mally associated with the use of BACTRIM patients. The incidence of hyperkalemia appears
compound in the blood reaches the concentrations usually achievable; other therapy should be selected.
be increased patients receiving BACTRIM. Adverse effects are generally severe patients receiving
Quality Control
BACTRIM for prophylaxis. history of mild intolerance BACTRIM in AIDS patients does not appear to pre-
Standardized susceptibility test procedures require the use of laboratory control microorganisms to control the
dic
intolerance of subsequent secondary prophylaxis. However, if a patient develops skin rash or any sign
technical aspects of the laboratory procedures. Standard sulfamethoxazole/trimethoprim powder should pro-
of adverse reaction, therapy with BACTRIM should be reevaluated (see WARNINGS).
vide the following range values:
High dosage of trimethoprim, as used in patients with Pneumocystis carinii pneumonia, induces progressive
Microorganism
MIC (ug/mL)
but
reversible
increase
serum
potassium
concentrations
substantia
number
of
patients.
Even
treat-
Escherichia coli
ATCC 25922
s0 5/9.
ment with recommended doses may cause hyperkalemia when trimethoprim administered to patients with
Haemophilus influenzaec
ATCC 49247
0.03/0.59 0.25/4.75
underlying disorders of potassium metabolism, with renal insufficiency, or if drugs known to induce hyper-
Streptococcus pneumoniaed
ATCC 49619
0.12/2.4
kalemia are given concomitantly. Close monitoring of serum potassium warranted in these patients.
During treatment, adequate fluid intake and urinary output should be ensured to prevent crystalluria. Patients who
are "slow acetylators' may be more prone to idiosyncratic reactions to sulfonamides.
priate blood chemistries, including electrolytes. If a significant blood dyscrasia or jaundice occurs, specific
Information for Patients: Patients should be instructed to maintain an adequate fluid intake in order to pre-
therapy should instituted for these complications Peritoneal dialysis not effective and hemodialysis
vent crystalluria and stone formation
only
moderately
effective
in
eliminating
sulfamethoxazole
and
trimethoprim.
Laboratory Tests: Complete blood counts should be done frequently patients receiving BACTRIM; if sig-
Chronic: Use of BACTRIM at high doses and/or for extended periods of time may cause bone marrow depres-
nificant reduction in the count of any formed blood element is noted, BACTRIM should be discontinued. Uri-
manifested as thrombocytopenia, leukopenia and/or megaloblastic anemia. signs of bone marrow depres-
nalyses with careful microscopic examination and renal function tests should be performed during therapy,
sion occur, the patient should be given leucovorin to mg daily until norma hematopoiesis restored.
particularly for those patients with impaired renal function.
DOSAGE AND ADMINISTRATION
Drug Interactions: In elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased
Not recommended for use in pediatric patients less than 2 months of age.
incidence
thrombocytopenia
with
purpura
has
reported.
Urinary
Tract
Infections
and
Shigellosis
in
Adults
and
Pediatric
Patients,
and
Acute
Otitis
Media
in
Children:
It
has been reported that BACTRIM may prolong the prothrombin time patients who are receiving the anti-
Adults: The usual adult dosage the treatment of urinary tract infections is BACTRIM DS (double strength)
coagulant warfarin. This interaction should kept mind when BACTRIM given patients already anti-
tablet, BACTRIM tablets every 12 hours for 10 to 14 days An identica daily dosage is used for 5 days in
coagulant
therapy,
and
the
coagulation
time
should
be
reassessed.
the
treatment
of
shigellosis
BACTRIM may inhibit the hepatic metabolism phenytoin. BACTRIM, given at a common clinical dosage increased
Children: The recommended dose for children with urinary tract infections or acute otitis media 40 mg/kg
the phenytoin by 39% and decreased the phenytoin metabolic clearance rate by 27%. When administering
sulfamethoxazole and mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 10
these drugs concurrently, one should be alert for possible excessive phenytoin effect.
days
identical
daily
dosage
used
for
days
the
treatment
of
shigellosis.
The
following
table
is
guide-
Sulfonamides can also displace methotrexate from plasma protein binding sites and can compete with the renal
line for the attainment of this dosage
transport methotrexate, thus increasing free methotrexate concentrations.
Children 2 months of age or older:
There have been reports of marked but reversible nephrotoxicity with coadministration of BACTRIM and
Weight
Dose--every 12 hours
cyclosporine rena transplant recipients
kg
Tablets
Increased digoxin blood levels can occur with concomitant BACTRIM therapy, especially in elderly patients.
Serum digoxin levels should be monitored
Increased sulfamethoxazole blood levels may occur in patients who are receiving indomethacin.
66
1/2
Occasiona reports suggest that patients receiving pyrimethamine as malaria prophylaxis in doses exceeding 25
88
40
2 or DS tablet
mg weekly may develop megaloblastic anemia BACTRIM prescribed.
The efficacy of tricyclic antidepressants can decrease when coadministered with BACTRIM.
For Patients with Impaired Renal Function: When renal function is impaired, a reduced dosage should be
employed using the following table:
Like other sulfonamide-containing drugs, BACTRIM potentiates the effect of oral hypoglycemics.
In the literature single case toxic delirium has been reported after concomitant intake of trimethoprim/sul-
Creatinine
Recommended
famethoxazole and amantadine.
Clearance (mL/min)
Dosage Regimen
Drug/Laboratory Test Interactions: BACTRIM, specifically the trimethoprim component can interfere with serum
Above 30
Usual standard regimen
methotrexate assay as determined by the competiti binding protein technique (CBPA) when a bacterial dihy-
15-30
1/2 the usual regimen
drofolate reductase used as the binding protein. No interference occurs, however, if methotrexate is measured
Below 15
Use not recommended
by radioimmunoassay (RIA).
The presence of sulfamethoxazole and trimethoprim may also interfere with the Jaffe alkaline picrate reaction
Acute Exacerbations of Chronic Bronchitis in Adults:
assay for creatinine, resulting overestimations of about 10% the range of normal values.
The usual adult dosage the treatment of acute exacerbations of chronic bronchitis is BACTRIM DS (double
Carcinogenesis, Mutagenesis, Impairment of Fertility:
strength) tablet, 2 BACTRIM tablets every 12 hours for 14 days.
Carcinogenesis: Long-term studies in animals to evaluate carcinogenic potential have not been conducted with
Pneumocystis Carinii Pneumonia:
BACTRIM.
Treatment: Adults and Children:
Mutagenesis: Bacterial mutagenic studies have not been performed with sulfamethoxazole and trimethoprim
The recommended dosage for patients with documented Pneumocystis carinii pneumonia is 75 to 100 mg/kg sul-
combination. Trimethoprim was demonstrated to be nonmutagenic the Ames No chromosomal damage
famethoxazole and 15 to 20 mg/kg trimethoprim per 24 hours given in equally divided doses every 6 hours for 14
was
observed
in
human
leukocytes
vitro
with
sulfamethoxazole
and
trimethoprim
alone
in
combination
the
to 21 days.8 The following table is guideline for the upper limit of this dosage
concentrations used exceeded blood levels of these compounds following therapy with sulfamethoxazole and
leukocytes obtained from patients treated with sulfamethoxazole and trimethoprim
Weight
Dose- every 6 hours
revealed no chromosomal abnormalities.
ib
kg
Tablets
Impairment of Fertility No adverse effects fertility or general reproductive performance were observed in rats given
18
8
oral dosages as high as 350 mg/kg/day sulfamethoxazol plus mg/kg/day trimethoprim.
35
16
53
24
1/2
Pregnancy: Teratogenic Effects: Pregnancy Category rats, oral doses of 533 mg/kg or 200 mg/kg pro-
70
or DS tablet
duced teratologic effects manifested mainly as cleft palates
88
40
1/2
The highest dose which did not cause cleft palates rats was 512 mg/kg or 192 mg/kg trimethoprim when admin-
106
48
3 1/2 DS tablets
istered separately. In two studies in rats no teratology was observed when 512 mg/kg of sulfamethoxazole was
141
64
or tablets
used
combination
with
128
mg/kg
of
one
study,
however,
cleft
palates
were
observed
in
one
176
80
tablets
litter out of 9 when 355 mg/kg of sulfamethoxazole was used in combination with 88 mg/kg of trimethoprim.
rabbit studies, overall increase fetal loss (dead and resorbed and malformed conceptuses) was asso-
For the lower limit dose (75 mg/kg sulfamethoxazole and 15 mg/kg trimethoprim per 24 hours) administer 75%
ciated
with
doses
of
trimethoprim
6
times
the
human
therapeutic
dose.
of the dose in the above table.
While there are no large, well-controlled studies on the use of sulfamethoxazole and trimethoprim in pregnant
Prophylaxis:
women,
Brumfitt
and
Pursell,7
in
retrospective
study,
reported
the
outcome
of
186
pregnancies
during
which
Adults:
the mother received either placebo or sulfamethoxazole and trimethoprim. The incidence of congenital abnor-
The recommended dosage for prophylaxis in adults is BACTRIM DS (double strength) tablet daily.
malities was .5% (3 66) those who received placebo and 3.3% of 120) in those receiving sulfamethox.
Children:
azole and trimethoprim. There were no abnormalities the 10 children whose mothers received the drug during
the first trimester In separate survey Brumfitt and Pursell also found no congenital abnormalities in 35 chil-
For children, the recommended dose is 750 mg/m2 /day sulfamethoxazole with 150 mg/m2/day trimethoprim
dren whose mothers had received oral sulfamethoxazole and trimethoprim at the time of conception or shortly
given orally equally divided doses twice day on consecutive week. The tota daily dose should
thereafter.
not exceed 1600 mg sulfamethoxazole and 320 mg trimethoprim. The following table is a guideline for
the
Because sulfamethoxazole and trimethoprim may interfere with folic acid metabolism, BACTRIM should be used
attainment of this dosage children:
during
pregnancy
only
the
potential
benefit
justifies
the
potentia
risk
to
the
fetus.
Body Surface Area
-every 12 hours
Nonteratogenic Effects: See CONTRAINDICATIONS section.
(m2)
Tablets
Nursing Mothers: See CONTRAINDICATIONS section.
Pediatric Use: BACTRIM not recommended for infants younger than 2 months of age (see INDICATIONS
0.53
1/2
and CONTRAINDICATIONS sections).
1.06
Geriatric Use: Clinical studies of BACTRIM did not include sufficient numbers of subjects aged 65 and over
to
determine
whether
they
respond
differently
from
younger
subjects.
Traveler's Diarrhea in Adults:
There may be an increased risk severe adverse reactions in elderly patients particularly when complicating
For the treatment of traveler's diarrhea, the usual adult dosage is BACTRIM DS (double strength) tablet; 2
conditions
exist.
impaired
kidney
and/or
liver
function,
possible
folate
deficiency
concomitant
use
BACTRIM tablets every 12 hours for days.
other drugs. Severe skin reactions, generalized marrow suppression (see WARNINGS and ADVERSE
HOW SUPPLIED
REACTIONS sections), or a specific decrease in platelets (with or without purpura) are the most frequently
BACTRIMT TABLETS are supplied as follows:
reported severe adverse reactions in elderly patients. In those concurrently receiving certain diuretics, primarily
BACTRIMTI DS (double strength) (white. oval shaped, scored) containing 160 trimethoprim and
thiazides, an ncreased incidence of with purpura reported Increased digoxin blood
800 mg sulfamethoxazole bottles of 100 (NDC 64248-117-10) and 500 (NDC 64248-117-50) Imprint on tablets
levels
can
occur
with
concomitant
BACTRIM
therapy
especially
elderly
patients
Serum
digoxin
levels
should
(debossed): (front) BACTRIM DS; (back) WFHC.
be effects monitored are reversible Hematological by folinic changes acid therapy indicative Appropriate of folic dosage acid deficiency adjustments may should occur in be elderly made for patients. patients These with
BACTRIMTM TABLETS (white, round, scored) containing 80 mg trimethoprim and 400 mg sulfamethoxazole
impaired kidney function and duration should short as possible to minimize risks undesired
bottles of 100 (NDC 64248-004-10) Imprint on tablets (debossed) (front) BACTRIM; (back) WFHC.
reactions (see DOSAGE AND ADMINISTRATION section). The trimethoprim component of BACTRIM may cause
Store at controlled room temperature 159-30C (599-86%F).
hyperkalemia when administered to patients with underlying disorders of potassium metabolism, with renal
DISPENSE IN TIGHT, LIGHT-RESISTANT CONTAINER.
or when given with drugs known induce monitoring of serum
potassium
these
of
REFERENCES
warranted
patients
Discontinuation
BACTRIM
treatment
is
recommended
to
help
lower
potassium serum levels. Bactrim Tablets contain 1.8 mg sodium mEq) of sodium per tablet. Bactrim DS
Kremers Duvivier Heusghem Pharmacokinetic Studies of Co-Trimoxazole in Man after Single and
Repeated
Doses
Clin
Pharmacol.
Feb-Mar
14:112-117
Tablets contain mg (0.16 mEq) of sodium per tablet.
2.
Kaplan SA al Pharmacokinetic Profile of Trimethoprim-Sulfamethoxazole in Man. Infect Dis. Nov 1973;
Pharmacokinetics parameters for sulfamethoxazole were similar for geriatric subjects and younger adult sub-
128
(Suppl):
jects The mean maximum serum trimethoprim was higher and clearance trimetho.
Varoquaux O, et al Pharmacokinetics of the methoprim-sulfamethoxazole combination in the elderly Br
prim was lower geriatric subjects compared with younger subjects (see CLINICAL PHARMACOLOGY:
Clin
Pharmacol
1985;20;575-581
Geriatric Pharmacokinetics).
Rudoy RC, Nelson JD, Haltalin KC. Antimicrobial Agents Chemother. May 1974;5:439-443
ADVERSE REACTIONS
National Committee Clinical Laboratory Standards Methods Dilution Antimicrobial Susceptibility Tests
The most common adverse effects are gastrointestinal disturbances (nausea vomiting, anorexia) and allergic
for Bacteria that Grow Aerobically; Approved Standard Fourth Edition. NCCLS document M7-A4, Vol.17 No.
skin reactions (such rash RARE. and urticaria) HAVE FATALITIES ASSOCIATED SEVERE WITH ADMINISTRATION STEVENS. OF SUL-
NCCLS, Wayne, PA, January, 1997
FONAMIDES,
ALTHOUGH
OCCURRED
REACTIONS,
INCLUDING
Nationa
Committee
for
Clinical
_aboratory
Standards.
Performance
Standards
for
Antimicrobial
Disk
Sus-
JOHNSON
SYNDROME,
TOXIC
EPIDERMAL
NECROLYSIS,
FULMINANT
HEPATIC
NECROSIS,
ceptibility Tests Approved Standard Sixth Edition. NCCLS Document M2-A6, Vol.17, No.1, NCCLS, Wayne,
AGRANULOCYTOSIS, APLASTIC ANEMIA AND OTHER BLOOD DYSCRASIAS (SEE WARNINGS SECTION).
PA January 1997
Hardy DW, et al controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for sec-
Hematologic: Agranulocytosis aplastic anemia thrombocytopenia, leukopenia, neutropenia, hemolytic anemia,
megaloblastic anemia hypoprothrombinemia, methemoglobinemia, eosinophilia.
ondary prophy Pneumocystis carinii pneumonia patients with the acquired immunodeficiency syn-
drome
Engl
Med.
327:1842-1848
Allergic Reactions: Stevens Johnson syndrome, toxic epidermal necrolysis, anaphylaxis, allergic myocarditis
8 Brumfitt W, Pursell R frimethoprim/Sulfamethoxazole in the Treatment of Bacteriuria in Women J Infect
erythema
multiforme,
exfoliative
dermatitis,
angioedema,
drug
fever
chills,
purpura,
serum
Dis
Nov
1973:
sickness-like syndrome, generalized allergic reactions, generalized skin eruptions, photosensitivity conjunc-
Masur H. Prevention and treatment of Pneumocystis pneumonia. N Engl Med. 1992; 327:1853-1880.
tival and scleral injection, pruritus, urticaria and rash. addition, periarteritis nodosa and systemic lupus ery-
10. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents
thematosus have been reported.
infected
with
human
immunodeficiency
virus
MMWR.
1992;
41(RR-4):1-11
Gastrointestinal: Hepatitis (including cholestatic jaundice and hepatic necrosis), elevation of serum transami-
11. CDC Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human
and bilirubin, pseudomembranous enterocolitis, pancreatitis, stomatitis glossitis, nausea, emesis, abdom-
immunodeficiency virus. MMWR. 1991; 40(RR-2):1-13.
inal pain, diarrhea, anorexia.
Genitourinary: Renal failure, interstitial nephritis BUN and serum creatinine elevation, toxic nephrosis with olig
uria
and
anuria,
crystalluria
and
nephrotoxicity
association
with
cyclosporine
Manufactured for
Metabolic and Nutritional: Hyperkalemia (see PRECAUTIONS Use the Treatment of and Prophylaxis
WOMEN FIRST HEALTHCARE, INC.
for
Pneumocystis
Carinii
Pneumonia
in
Patients
with
Acquired
Immunodeficiency
Syndrome
(AIDS).
San Diego, CA 92130
Neurologic: Aseptic meningitis, convulsions, peripheral neuritis, ataxia, vertigo, tinnitus, headache.
www.womenfirst.com
Psychiatric: Hallucinations, depression, apathy, nervousness.
MUTUAL PHARMACEUTICAL COMPANY, INC.
Endocrine: The sulfonamides bear certain chemical similarities some goitrogens, diuretics (acetazolamide
Philadelphia, PA 19124
and the thiazides) and oral hypoglycemic agents ross-sensitivity may exist with these agents. Diuresis and
hypoglycemia have occurred rarely in patients receiving sulfonamides.
Musculoskeletal Arthralgia and myalgia. Isolated cases of rhabdomyolysis have been reported with BACTRIM,
mainly
AIDS
patients
Respiratory: Cough, shortness of breath and pulmonary infiltrates (see WARNINGS).
BA-02-04-1
WOMENFIRST
Miscellaneous: Weakness, fatigue, insomnia.
Revised: July 2002Ch
OVERDOSAGE
Acute: The amount of a single dose of BACTRIM that is either associated with symptoms of overdosage or is
likely
to
be
life-threatening
has
not
been
reported.
Signs
and
symptoms
of
overdosage
reported
with
sulfonamides
include anorexia, colic, nausea, vomiting dizziness, headache, drowsiness and unconsciousness. Pyrexia, hema-
turia and crystalluria may be noted. Blood dyscrasias and jaundice are potentia late manifestations overdosage
Signs of acute overdosage with trimethoprim include nausea, vomiting, dizziness, headache, mental depression,
confusion and bone marrow depression.
Genera principles of treatment include the institution of gastric lavage emesis, forcing oral fluids and admin-
istration
of
intravenous
fluids
urine
output
is
low
and
renal
function
is
normal
Acidification
of
the
urine
will
increase rena elimination of trimethoprim. The patient should be monitored with blood counts and appro-
This is a representation of an electronic record that was signed electronically and
this page is the manifestation of the electronic signature.
/s/
Janice Soreth
10/17/02 04:30:19 PM
